boc-l-tyr-ol

We are boc-l-tyr-ol CAS:220237-31-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: boc-l-tyr-ol
CAS.NO: 220237-31-0
Molecular Formula:C14H21NO4
Molecular Weight:267.32100

Synonyms:
n-t-butoxycarbonyl-l-tyrosinol
boc-tyrosinol
boc-l-tyrosinol
boc-(s)-2-amino-3-(4-hydroxy)phenyl-1-propanol
boc-tyr-ol
n-boc-l-tyrosinol

Physical and Chemical Properties:
Density:1.163g/cm3
Boiling point: 462.907°C at 760 mmHg
Melting point: 118-120ºC(lit.)
Flash point: 233.758°C
Refractive index: 1.541

Specification:
Appearance: White or Off-white Powder
Purity:≥98%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at 0ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.

boc-l-tyr-ol


Related News: Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing, thoroughly cooking meat and eggs. Avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing.ethyl N-(2-chloroethyl)carbamate Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing, thoroughly cooking meat and eggs. Avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing.2-oxo-6-(trifluoromethyl)-1H-pyridine-3-carboxylic acid CAS:191595-63-8 Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.1-methyl-3-methoxyoestra-1,3,5(10)-trien-17-one CAS:2684-40-4 Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities.

Related Products
Product Name
Acetyl Hexapeptide-49 View Details
Tetrapropylammonium hydroxide View Details
3-Bromo-2-chloro-5-methylpyridine View Details
3-Butyn-2-ol manufacturer 4-Chlorobenzaldehyde manufacturer 4,4-Dimethylcyclohexanone manufacturer bis(trichloromethyl) carbonate manufacturer (4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone manufacturer